A dose-response study of I3-cis-retinoic acid in acne vulgaris
- PMID: 6219690
- DOI: 10.1111/j.1365-2133.1983.tb03973.x
A dose-response study of I3-cis-retinoic acid in acne vulgaris
Abstract
13-cis-retinoic acid has been used as a single agent in the treatment of seventy-six patients with previously unresponsive cystonodular acne. The study was carried out in a double-blind fashion using three doses of the drug. Ninety per cent of the patients responded with a 70% improvement in the acne severity. Sixty-six per cent of the patients experienced no further problems with their acne during follow-up. Side-effects were frequent. The 0.5 mg/kg b.w. dose is recommended for the initial course of treatment.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical